Table 2 Average dosimetric parameters for patients with and without toxicity
Endpoint | Xerostomia | |
|---|---|---|
Toxicity | No toxicity | |
Number of patients | 19 | 36 |
Parotid mean ± std. dev. (Gy) | 16.2 ± 6.2 | 13.8 ± 4.7 |
Parotid V20 ± std. dev. (%) | 43.0 ± 19.5 | 34.6 ± 15.7 |
Endpoint | Dry eye | |
|---|---|---|
Toxicity | No toxicity | |
Number of patients | 13 | 41 |
Lacrimal mean ± std. dev. (Gy) | 26.6 ± 4.9 | 25.0 ± 6.7 |
Lacrimal V15 ± std. dev. (%) | 86.3 ± 15.7 | 78.3 ± 19.7 |